Home » Newsletters » BioWorld

BioWorld

Feb. 3, 1994

View Archived Issues

ANESTA COMPLETES IPO

MONSANTO TO LAUNCH RBGH POSILAC

MICROCARB MAY DEVELOP HUGHES' ANTIVIRAL COMPOUNDS

IMMUNOGEN CLOSING $11.1M OFFERING

VIMRX OFFERING RAISES $5.6M

UBI'S HIV VACCINE ENTERS PHASE I CLINICALS

PROCYTE COMPLETES $33M FOLLOW-ON OFFERING

LONDON STOCK EXCHANGE TO REVIEW BIOTECH RULES

GENPHARM DENIES STEALING CELL GENESYS TECHNOLOGY